Blood Pressure Control in ESH Excellence Centres (BP-CON)

March 3, 2020 updated by: Prof. Bojan Jelaković, Clinical Hospital Centre Zagreb

Study of the European Society of Hypertension on Blood Pressure Control in ESH Excellence Centres

In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually done in the office, but care will be adopted to make measurements highly standardized in all Centres. The primary goals will be to determine the global, regional and country rates of hypertension control in Europe. Other goals will be to identify global and regional factors associated with blood pressure control in different European regions. The results obtained in the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood pressure control and will serve as a basis for assessing future changes and trends in Europe.

Study Overview

Detailed Description

The most important task of the European Society of Hypertension is to improve blood pressure treatment and increase blood pressure control, thus decreasing cardiovascular risk, premature cardiovascular and renal morbidity and mortality, with in addition a reduction of health-care costs. More than a decade ago, the European Society of Hypertension established a network of Excellence Centres. Those centres are leading institutions for the diagnosis and treatment of hypertension and thus are front runners of good clinical practice in hypertension management in their countries. An important task of the Excellence Centres is also to be active in research, particularly in projects conducted by the European Society of Hypertension. The ongoing BP-CON-ESH project on the rate of blood pressure control in hypertensive patients addresses the most elementary,but at the same timethe most important aspect in hypertension management, because the observed low rates of blood pressure control is the reason why hypertension is still today the leading cause of death worldwide.

In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually done in the office, but care will be adopted to make measurements highly standardized in all Centres.

The primary goals will be to determine the global, regional and country rates of hypertension control in Europe. Other goals will be to identify global and regional factors associated with blood pressure control in different European regions. It is well known that the overall control of hypertension in Europe is still insufficient. However, the problem is not the same across Europe. Differences in healthcare systems exist among European countries, and in some countries government healthcare system only partially reimburse costs of antihypertensive therapy. There are also differences in gross national product, educational levels, salt consumption, prevalence of obesity and other aspects. These could cause dissimilarities in hypertension prevalence, achieved blood pressure control and cardiovascular mortality among European regions.

The results obtained in the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood pressure control and will serve as a basis for assessing future changes and trends in Europe.

Study Type

Observational

Enrollment (Anticipated)

3000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Yerevan, Armenia, 0014
        • Recruiting
        • Center of Preventive Cardiology, Yerevan
        • Contact:
      • Wels, Austria, 4600
      • Sofia, Bulgaria, 1750
        • Recruiting
        • University Hospital "St. Anna"
        • Contact:
    • Grad Zagreb
      • Zagreb, Grad Zagreb, Croatia, 10000
        • Recruiting
        • University Hospital Centre Zagreb
        • Contact:
      • Plzen, Czechia, 30599
        • Recruiting
        • Charles University Medical School and University Hospital
        • Contact:
      • Praha, Czechia, 12808
        • Recruiting
        • Center for Hypertension, Charles University, Prague
        • Contact:
      • Praha, Czechia, 14059
        • Recruiting
        • Institute for Clinical and Experimental Medicine (IKEM) and Thomayer Hospital, Prague
        • Contact:
      • Berlin, Germany, 10117
      • Bonn, Germany, 53123
        • Not yet recruiting
        • Hypertoniezentrum Bonn
        • Contact:
      • Hanover, Germany, 30625
      • Homburg, Germany, D-66421
        • Recruiting
        • Universitätskliniken des Saarlandes
        • Contact:
      • Munich, Germany, 80333
      • Athens, Greece, 10676
        • Recruiting
        • Hypertension and Cardiovascular Prevention Clinic, 3rd Department of Medicine, Evangelismos Hospital
        • Contact:
      • Athens, Greece, 11527
        • Recruiting
        • Hypertension Clinic, University Hospital Laiko
        • Contact:
      • Athens, Greece, 11527
        • Recruiting
        • University of Athens, Hippokration Hospital
        • Contact:
      • Athens, Greece, 14561
        • Recruiting
        • Hypertension Clinic, Department of Cardiology, KAT General Hospital
        • Contact:
      • Athens, Greece
        • Recruiting
        • Hypertension Clinic, Cardiology Department, Asklepeion Hospital
        • Contact:
      • Heraklion, Greece, 71110
      • Ioánnina, Greece, 45500
        • Recruiting
        • Hypertension Center, Department of Nephrology, University Hospital of Ioannina
        • Contact:
      • Thessaloníki, Greece, 54636
        • Recruiting
        • Hypertension Outpatient Clinic, 1st Propedeutic Dept. of Internal Medicine, AHEPA Hospital
        • Contact:
        • Contact:
      • Thessaloníki, Greece, 54642
        • Recruiting
        • Hypertension Center, Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki
        • Contact:
      • Thessaloníki, Greece, 56403
        • Recruiting
        • Aristotle University of Thessaloniki, Papageorgiou General Hospital
        • Contact:
      • Ashdod, Israel, 7747629
        • Not yet recruiting
        • Assuta Ashdod University Hospital
        • Contact:
      • Brescia, Italy
        • Not yet recruiting
        • Centre of Prevention and Treatment of Arterial Hypertension and Cardiovascular Risk Factors
        • Contact:
      • Milan, Italy, 20149
      • Milan, Italy, 20162
      • Napoli, Italy, 80131
        • Not yet recruiting
        • Napoli Hypertension Excellence Centre, Federico II Clinic Research Center for Hypertension and Related Conditions
        • Contact:
      • Torino, Italy, 10124
        • Not yet recruiting
        • Excellence Centre of Hypertension, Department of Medical Sciences, University of Torino
        • Contact:
      • Beirut, Lebanon
        • Not yet recruiting
        • American University Center, Hypertension/Vascular Medicine Division (Associated Centre)
        • Contact:
      • Kaunas, Lithuania, 47101
        • Not yet recruiting
        • Kaunas Hypertension Excellence Centre
        • Contact:
      • Maastricht, Netherlands, 6229 HX
      • Nijmegen, Netherlands, 6525 GA
        • Not yet recruiting
        • Radboud University of Nijmegen Medical Center
        • Contact:
      • Warsaw, Poland, 02-091
        • Not yet recruiting
        • Department of Internal Medicine, Hypertension and Vascular Diseases, Warsaw Medical University
        • Contact:
      • Guimarães, Portugal
        • Recruiting
        • Centro Hospitalar do Alto Ave, Minho University
        • Contact:
      • Bucharest, Romania
        • Recruiting
        • Department of Cardiology and Internal Medicine, Emergency Clinical Hospital of Bucharest
        • Contact:
      • Belgrad, Serbia, 11000
        • Recruiting
        • Centre for Hypertension of the Clinical Centre of Serbia
        • Contact:
      • Barcelona, Spain, 08036
        • Not yet recruiting
        • Hipertensión Clinic, Internal Medicine, Hospital Clinico, University of Barcelona
        • Contact:
      • Córdoba, Spain, 14004
        • Not yet recruiting
        • Hypertension Clinic, Nephrology Department, Reina Sofia University Hospital
        • Contact:
      • Stockholm, Sweden, 182 57
        • Not yet recruiting
        • Danderyd University Hospital
        • Contact:
      • Kyiv, Ukraine, 02000
        • Not yet recruiting
        • National Scientific Center "The M.D. Strazhesko Institute of Cardiology"
        • Contact:
      • London, United Kingdom, E1 2AD
        • Not yet recruiting
        • St. Bartholomew's Royal London School of Medicine & Dentistry
        • Contact:
      • London, United Kingdom, W12 0HS
        • Not yet recruiting
        • The Pearl-Rose Clinic (Hypertension & Cardiovascular Risk), Hammersmith Hospital,
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with hypertension that are under supervision of excellence centres participating in the study.

Description

Inclusion Criteria:

  • Signed informed consent

Exclusion Criteria:

  • Pregnancy and breastfeeding
  • Terminal malignancy, reduced life expectancy (<6 months)
  • Amputated limb
  • Dementia
  • Patients living in a nursing home
  • Unsigned informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure control
Time Frame: Through study completion, an average of 1 year
Difference in blood pressure values between ESH Excellence Centres
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bojan Jelaković, MD, PhD, Clinical Hospital Centre Zagreb

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2018

Primary Completion (Anticipated)

October 1, 2020

Study Completion (Anticipated)

March 1, 2021

Study Registration Dates

First Submitted

February 26, 2020

First Submitted That Met QC Criteria

March 3, 2020

First Posted (Actual)

March 4, 2020

Study Record Updates

Last Update Posted (Actual)

March 4, 2020

Last Update Submitted That Met QC Criteria

March 3, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on White Coat Hypertension

3
Subscribe